Press release 📈 Stocks 🌍 United States

Becton Dickinson Marks 85 Years of Manufacturing at Glens Falls Facility

BD commemorates 85 years of production at its Glens Falls, NY plant, a site that now supports 825 SKUs and employs 550 staff members to supply essential medical technologies globally.

🕐 1 min read

1 assets impacted (Stocks). Net bias: 0 Bullish, 0 Bearish, 1 Neutral. Strongest signal: BDX → 1/10 (80% confidence).

📊 Affected Assets (1)

BDX
Neutral 🤖 80%
⚡ Intraday 🌍 US · Explicit

A PR celebrating the 85th anniversary of the Glens Falls, NY manufacturing site, which makes ~6.5 million devices annually with ~550 associates. It is a milestone and community-story announcement with no earnings, guidance, order or regulatory content that would change BD's valuation outlook.

🧭 Full analysis of these assets

🎯 Key Takeaways

  • The Glens Falls site produces approximately 6.5 million medical devices annually.
  • The facility currently employs about 550 associates with over 5,800 years of combined experience.
  • The site manages a portfolio of 825 SKUs across 20 product lines including vascular and cardiac care.
  • BD donated $10,000 to the Open Door Mission as part of the anniversary celebration.

📝 Executive Summary

Becton Dickinson (BD) is celebrating the 85th anniversary of its manufacturing site in Glens Falls, New York. The facility, which began operations in 1941, currently employs approximately 550 associates and produces 6.5 million medical devices annually across 20 product lines.

❓ FAQ

Does the 85th anniversary of the Glens Falls plant change anything for BD investors?

No. The release notes the site produces about 6.5 million devices a year with roughly 550 employees and includes a $10,000 donation, but contains no new financial results, guidance or contracts.